Volume 30, Issue 5 pp. 377-383
Research Article

Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence

Carlos De las Cuevas

Corresponding Author

Carlos De las Cuevas

Department of Internal Medicine, Dermatology and Psychiatry, University of La Laguna, San Cristóbal de La Laguna, Canary Islands, Spain

Correspondence to: C. De las Cuevas, Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, University of La Laguna, Campus de Ofra s/n, 38071 San Cristóbal de La Laguna, Spain. Tel: 0034609521405; Fax: 0034 922 319 353 E-mail: [email protected]Search for more papers by this author
Wenceslao Peñate

Wenceslao Peñate

Department of Personality, Assessment and Psychological Treatments, University of La Laguna, San Cristóbal de La Laguna, Canary Islands, Spain

Search for more papers by this author
First published: 25 May 2015
Citations: 18

Abstract

Objective

The objective of this study is to assess psychiatric patient attitudes towards psychotropic medication and their association with adherence, as well as to identify the factors that influence these attitudes.

Methods

Nine hundred and forty nine consecutive psychiatric outpatients categorized as “pharmacophobic” or “pharmacophilic” according to the Drug Attitude Inventory were compared with regard to adherence to prescribed treatment, socio-demographic variables, clinical characteristics, health locus of control, self-efficacy, and psychological reactance.

Results

Seventy three per cent of psychiatric outpatients showed a “pharmacophilic” attitude and 15.5% “pharmacophobic” one. Patients' attitudes toward prescribed drug treatment were clearly related to self-reported treatment adherence. The pharmacophobic group registered significant worse adherence than the pharmacophilic patients. Psychiatric patients’ attitudes to drugs were mediated by external health locus of control, cognitive psychological reactance, and self-efficacy.

Conclusion

The encouragement of psychiatric patients’ treatment adherence needs to include lack of coercion during prescription, a positive relationship with the prescriber, verbal persuasion, information containing vicarious experience, and the involvement of the patient in treatment decisions. Copyright © 2015 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.